These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23114161)

  • 1. [Research advances of extramedullary relapse in multiple myeloma - review].
    Wang J; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1261-6. PubMed ID: 23114161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
    Bladé J; Fernández de Larrea C; Rosiñol L; Cibeira MT; Jiménez R; Powles R
    J Clin Oncol; 2011 Oct; 29(28):3805-12. PubMed ID: 21900099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
    Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
    Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data.
    Sevcikova S; Paszekova H; Besse L; Sedlarikova L; Kubaczkova V; Almasi M; Pour L; Hajek R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):288-93. PubMed ID: 25877407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma.
    Erkus M; Bolaman Z; Meteoglu I; Kadikoylu G
    Saudi Med J; 2005 Jun; 26(6):989-91. PubMed ID: 15983690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma with extramedullary disease.
    Oriol A
    Adv Ther; 2011 Nov; 28 Suppl 7():1-6. PubMed ID: 22105527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
    Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
    Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases.
    Rasche L; Bernard C; Topp MS; Kapp M; Duell J; Wesemeier C; Haralambieva E; Maeder U; Einsele H; Knop S
    Ann Hematol; 2012 Jul; 91(7):1031-7. PubMed ID: 22286070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28, a marker associated with tumoral expansion in multiple myeloma.
    Robillard N; Jego G; Pellat-Deceunynck C; Pineau D; Puthier D; Mellerin MP; Barillé S; Rapp MJ; Harousseau JL; Amiot M; Bataille R
    Clin Cancer Res; 1998 Jun; 4(6):1521-6. PubMed ID: 9626472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics of extramedullary manifestations in multiple myeloma.
    Billecke L; Murga Penas EM; May AM; Engelhardt M; Nagler A; Leiba M; Schiby G; Kröger N; Zustin J; Marx A; Matschke J; Tiemann M; Goekkurt E; Heidtmann HH; Vettorazzi E; Dierlamm J; Bokemeyer C; Schilling G
    Br J Haematol; 2013 Apr; 161(1):87-94. PubMed ID: 23368088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation.
    Trullemans F; Schots R; Storme G; Camp BV
    Bone Marrow Transplant; 2000 Jan; 25(1):115-7. PubMed ID: 10654026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?
    Katodritou E; Gastari V; Verrou E; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Laschos K; Xirou P; Yiannaki E; Constantinou N; Markala D; Zervas K
    Leuk Res; 2009 Aug; 33(8):1137-40. PubMed ID: 19250676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relapse of multiple myeloma in extramedullary sites].
    Bairey O; Huminer D; Blickstein D; Sandbank Y; Shaklai M
    Harefuah; 1993 May; 124(9):539-41, 600. PubMed ID: 8340001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas.
    Zomas A; Stefanoudaki K; Fisfis M; Papadaki T; Mehta J
    Bone Marrow Transplant; 1998 Jun; 21(11):1163-5. PubMed ID: 9645583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
    Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
    Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
    Bianchi G; Anderson KC
    CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.